Brief: Klaria Pharmaceuticals Enters Into Agreement With Fluimed
March 30 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* KLARIA PHARMACEUTICALS ENTERS INTO AGREEMENT WITH FLUIMED
GMBH
TO DEVELOP SIROLIMUS ALGINATE FILM FOR PREVENTION OF ORGAN
TRANSPLANT REJECTION
* AS PART OF AGREEMENT, KLARIA WILL RECEIVE UPFRONT PAYMENTS
OF CA
SEK 10 MILLION.
Source text for Eikon: ID:nWkr6jMH9Q
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement